141 related articles for article (PubMed ID: 35832474)
1. Screening of subclinical P300 event-related potentials changes in childhood acute lymphoblastic leukemia survivors.
Kroczka S; Kwiecinska K; Gergont A; Grela A; Gorowska O; Skoczen S
Mol Clin Oncol; 2022 Aug; 17(2):125. PubMed ID: 35832474
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols.
Kroczka S; Stepien K; Witek-Motyl I; Kwiecinska K; Kapusta E; Biedron A; Skorek P; Skoczen S
BMC Cancer; 2021 Feb; 21(1):150. PubMed ID: 33568096
[TBL] [Abstract][Full Text] [Related]
3. Polyneuropathy in Acute Lymphoblastic Leukemia Long-Term Survivors: Clinical and Electrophysiological Characteristics With the Impact of Radiotherapy.
Kroczka S; Stepien K; Witek-Motyl I; Klekawka T; Kapusta E; Biedron A; Skorek P; Twardowska H; Stasik K; Skoczen S
Front Pediatr; 2020; 8():526235. PubMed ID: 33634049
[No Abstract] [Full Text] [Related]
4. [Assessment of congitive functions in patients post acute lymphoblastic leukemia treatment used P300 event related potential].
Kroczka S; Steczkowska-Klucznik M; Kaciński M; Skoczeń S
Przegl Lek; 2006; 63 Suppl 1():4-7. PubMed ID: 17471816
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials.
Lähteenmäki PM; Holopainen I; Krause CM; Helenius H; Salmi TT; Heikki LA
Med Pediatr Oncol; 2001 Apr; 36(4):442-50. PubMed ID: 11260567
[TBL] [Abstract][Full Text] [Related]
6. P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood--side effects of CNS prophylaxis?
Uberall MA; Haupt K; Meier W; Hertzberg H; Beck JD; Wenzel D
Neuropediatrics; 1996 Jun; 27(3):130-5. PubMed ID: 8837072
[TBL] [Abstract][Full Text] [Related]
7. [Effect of mental fatigue induced by repeated continuous calculation tasks on event-related brain potential (P300)].
Okamura N
Sangyo Eiseigaku Zasshi; 2007 Sep; 49(5):203-8. PubMed ID: 17938559
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia.
Skoczen S; Tomasik PJ; Bik-Multanowski M; Surmiak M; Balwierz W; Pietrzyk JJ; Sztefko K; Gozdzik J; Galicka-Latała D; Strojny W
J Exp Clin Cancer Res; 2011 Jun; 30(1):64. PubMed ID: 21631924
[TBL] [Abstract][Full Text] [Related]
9. Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China.
Fu Y; Wang H; Zhai X; Qian X; Meng J; Miao H; Zhu X; Yu Y; Lu F
J Pediatr Hematol Oncol; 2019 Apr; 41(3):170-174. PubMed ID: 30664102
[TBL] [Abstract][Full Text] [Related]
10. Seizure frequency affects event-related potentials (P300) in epilepsy.
Chen RC; Tsai SY; Chang YC; Liou HH
J Clin Neurosci; 2001 Sep; 8(5):442-6. PubMed ID: 11535014
[TBL] [Abstract][Full Text] [Related]
11. [Long latency auditory evoked potentials in schoolchildren and adolescents with epilepsy].
Zgorzalewicz M
Przegl Lek; 2006; 63 Suppl 1():8-13. PubMed ID: 17471817
[TBL] [Abstract][Full Text] [Related]
12. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.
Stark B; Sharon R; Rechavi G; Attias D; Ballin A; Cividalli G; Burstein Y; Sthoeger D; Abramov A; Zaizov R
Cancer; 2000 Jan; 88(1):205-16. PubMed ID: 10618625
[TBL] [Abstract][Full Text] [Related]
13. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Burkhardt B; Woessmann W; Zimmermann M; Kontny U; Vormoor J; Doerffel W; Mann G; Henze G; Niggli F; Ludwig WD; Janssen D; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2006 Jan; 24(3):491-9. PubMed ID: 16421426
[TBL] [Abstract][Full Text] [Related]
14. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.
Saxena N; Bhatia M; Joshi YK; Garg PK; Tandon RK
J Gastroenterol Hepatol; 2001 Mar; 16(3):322-7. PubMed ID: 11339425
[TBL] [Abstract][Full Text] [Related]
15. The value of P300 event related potentials in the assessment of cognitive function in subclinical hypothyroidism.
Dejanović M; Ivetić V; Nestorović V; Milanović Z; Erić M
Minerva Endocrinol; 2017 Mar; 42(1):15-23. PubMed ID: 26337490
[TBL] [Abstract][Full Text] [Related]
16. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Schober S; Arlt I; Loewke M; Henze G
Blood; 1994 Jun; 83(12):3468-72. PubMed ID: 8204875
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
[TBL] [Abstract][Full Text] [Related]
18. Auditory event-related potentials in benign childhood epilepsy with centrotemporal spike: the effects of carbamazepine.
Naganuma Y; Konishi T; Hongou K; Murakami M; Yamatani M; Yagi S; Okada T
Clin Electroencephalogr; 1994 Jan; 25(1):8-12. PubMed ID: 8174292
[TBL] [Abstract][Full Text] [Related]
19. P300 component identification using source analysis techniques: reduced latency variability.
Elting JW; van Weerden TW; van der Naalt J; De Keyser JH; Maurits NM
J Clin Neurophysiol; 2003 Feb; 20(1):26-34. PubMed ID: 12684555
[TBL] [Abstract][Full Text] [Related]
20. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
